1887

Abstract

The Epstein–Barr virus latent membrane protein (LMP 1) functions as a constitutively active signalling molecule and associates in lipid rafts clustered with other signalling molecules. Using immunofluorescent confocal microscopy, LMP 1 was shown to have an heterogeneous distribution among individual cells which was not related to the cell cycle stage. LMP 1 was shown to localize to intracellular compartments in cells other than the plasma membrane. Co-labelling of cells with both an LMP 1 antibody and an antibody to the Golgi protein GS15 revealed that the intracellular LMP 1 partly co-localized with the Golgi apparatus. Further confirmation of intracellular LMP 1 localization was obtained by immunoelectron microscopy with rabbit polyclonal LMP 1 antibodies and cryosectioning. As well as being present in intracellular foci, LMP 1 co-localized in part with MHC-II and was present on exosomes derived from a lymphoblastoid cell line. Preparations of LMP 1 containing exosomes were shown to inhibit the proliferation of peripheral blood mononuclear cells, suggesting that LMP 1 could be involved in immune regulation. This may be of particular relevance in EBV-associated tumours such as nasopharyngeal carcinoma and Hodgkin's disease, as LMP 1-containing exosomes may be taken up by infiltrating T-lymphocytes, where LMP 1 could exert an anti-proliferative effect, allowing the tumour cells to evade the immune system.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.18944-0
2003-07-01
2020-07-07
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/7/vir841871.html?itemId=/content/journal/jgv/10.1099/vir.0.18944-0&mimeType=html&fmt=ahah

References

  1. Andrews N. W.. 2000; Regulated secretion of conventional lysosomes. Trends Cell Biol10:316–321
    [Google Scholar]
  2. Ardila-Osorio H., Clausse B., Mishal Z., Wiels J., Tursz T., Busson P.. 1999; Evidence of LMP1–TRAF3 interactions in glycosphingolipid-rich complexes of lymphoblastoid and nasopharyngeal carcinoma cells. Int J Cancer81:645–649
    [Google Scholar]
  3. Baichwal V. R., Sugden B.. 1987; Posttranslational processing of an Epstein–Barr virus-encoded membrane protein expressed in cells transformed by Epstein–Barr virus. J Virol61:866–875
    [Google Scholar]
  4. Benaroch P., Yilla M., Raposo G., Ito K., Miwa K., Geuze H. J., Ploegh H. L.. 1995; How MHC class II molecules reach the endocytic pathway. EMBO J14:37–49
    [Google Scholar]
  5. Bloss T., Kaykas A., Sugden B.. 1999; Dissociation of patching by latent membrane protein-1 of Epstein–Barr virus from its stimulation of NF- κ B activity. J Gen Virol80:3227–3232
    [Google Scholar]
  6. Boos H., Berger R., Kuklik-Roos C., Iftner T., Mueller-Lantzsch N.. 1987; Enhancement of Epstein–Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells. Virology159:161–165
    [Google Scholar]
  7. Chiu I., Davis D. M., Strominger J. L.. 1999; Trafficking of spontaneously endocytosed MHC proteins. Proc Natl Acad Sci U S A96:13944–13949
    [Google Scholar]
  8. Clausse B., Fizazi K., Walczak V., Tetaud C., Wiels J., Tursz T., Busson P.. 1997; High concentration of the EBV latent membrane protein 1 in glycosphingolipid-rich complexes from both epithelial and lymphoid cells. Virology228:285–293
    [Google Scholar]
  9. Dantuma N., Massucci M.. 2003; The ubiquitin/proteasome system in Epstein–Barr virus infection and related malignancies. Semin Cancer Biol (in Press)
    [Google Scholar]
  10. Denzer K., Kleijmeer M. J., Heijnen H. F., Stoorvogel W., Geuze H. J.. 2000; Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci113:3365–3374
    [Google Scholar]
  11. Dukers D. F., Meij P., Vervoort M. B., Vos W., Scheper R. J., Meijer C. J., Bloemena E., Middeldorp J. M.. 2000; Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J Immunol165:663–670
    [Google Scholar]
  12. Gires O., Zimber-Strobl U., Gonnella R., Ueffing M., Marschall G., Zeidler R., Pich D., Hammerschmidt W.. 1997; Latent membrane protein 1 of Epstein–Barr virus mimics a constitutively active receptor molecule. EMBO J16:6131–6140
    [Google Scholar]
  13. Hudson G. S., Bankier A. T., Satchwell S. C., Barrell B. G.. 1985; The short unique region of the B95-8 Epstein–Barr virus genome. Virology147:81–98
    [Google Scholar]
  14. Kopito R. R.. 2000; Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol10:524–530
    [Google Scholar]
  15. Laszlo L., Tuckwell J., Self T., Lowe J., Landon M., Smith S., Hawthorne J. N., Mayer R. J.. 1991; The latent membrane protein-1 in Epstein–Barr virus-transformed lymphoblastoid cells is found with ubiquitin-protein conjugates and heat-shock protein 70 in lysosomes oriented around the microtubule organizing centre. J Pathol164:203–214
    [Google Scholar]
  16. Lelouard H., Gatti E., Cappello F., Gresser O., Camosseto V., Pierre P.. 2002; Transient aggregation of ubiquitinated proteins during dendritic cell maturation. Nature417:177–182
    [Google Scholar]
  17. Liebowitz D., Kieff E.. 1989; Epstein–Barr virus latent membrane protein: induction of B-cell activation antigens and membrane patch formation does not require vimentin. J Virol63:4051–4054
    [Google Scholar]
  18. Liebowitz D., Wang D., Kieff E.. 1986; Orientation and patching of the latent infection membrane protein encoded by Epstein–Barr virus. J Virol58:233–237
    [Google Scholar]
  19. Liebowitz D., Kopan R., Fuchs E., Sample J., Kieff E.. 1987; An Epstein–Barr virus transforming protein associates with vimentin in lymphocytes. Mol Cell Biol7:2299–2308
    [Google Scholar]
  20. Mann K. P., Staunton D., Thorley-Lawson D. A.. 1985; Epstein–Barr virus-encoded protein found in plasma membranes of transformed cells. J Virol55:710–720
    [Google Scholar]
  21. Meij P., Vervoort M. B. H. J., Meijer C. J. L. M., Bloemena E., Middeldorp J. M.. 2000; Production monitoring and purification of EBV encoded latent membrane protein 1 expressed and secreted by recombinant baculovirus infected insect cells. J Virol Methods90:193–204
    [Google Scholar]
  22. Morales C. R., Zhao Q., Lefrancois S.. 1999; Biogenesis of lysosomes by endocytic flow of plasma membrane. Biocell23:149–160
    [Google Scholar]
  23. Musch A., Cohen D., Kreitzer G., Rodriguez-Boulan E.. 2001; cdc42 regulates the exit of apical and basolateral proteins from the trans-Golgi network. EMBO J20:2171–2179
    [Google Scholar]
  24. Oudejans J. J., Jiwa N. M., Kummer J. A.. 7 other authors 1997; In situ detection of activated cytotoxic cells in Hodgkin's disease biopsies: recognition of cases with poor clinical outcome. Blood89:1376–1382
    [Google Scholar]
  25. Oudejans J. J., Harijadi A., Kummer J. A.. 7 other authors 2003; High numbers of granzyme B/CD8 positive tumour infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcome in patients treated with curative intent. J Pathol (in press)
    [Google Scholar]
  26. Puls A., Eliopoulos A. G., Nobes C. D., Bridges T., Young L. S., Hall A.. 1999; Activation of the small GTPase Cdc42 by the inflammatory cytokines TNF(alpha) and IL-1, and by the Epstein–Barr virus transforming protein LMP1. J Cell Sci112:2983–2992
    [Google Scholar]
  27. Raposo G., Nijman H. W., Stoorvogel W., Liejendekker R., Harding C. V., Melief C. J., Geuze H. J.. 1996; B lymphocytes secrete antigen-presenting vesicles. J Exp Med183:1161–1172
    [Google Scholar]
  28. Rowe M., Evans H. S., Young L. S., Hennessy K., Kieff E., Rickinson A. B.. 1987; Monoclonal antibodies to the latent membrane protein of Epstein–Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. J Gen Virol68:1575–1586
    [Google Scholar]
  29. Sanderson F., Kleijmeer M. J., Kelly A., Verwoerd D., Tulp A., Neefjes J. J., Geuze H. J., Trowsdale J.. 1994; Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science266:1566–1569
    [Google Scholar]
  30. Skokos D., Le-Panse S., Villa I., Rousselle J. C., Peronet R., David B., Namane A., Mecheri S.. 2001; Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J Immunol166:868–876
    [Google Scholar]
  31. Smyth C., Logan G., Weinberger R. P., Rowe P. B., Alexander I. E., Smythe J. A.. 1998; Identification of a dynamic intracellular reservoir of CD86 protein in peripheral blood monocytes that is not associated with the Golgi complex. J Immunol160:5390–5396
    [Google Scholar]
  32. Wang D., Liebowitz D., Kieff E.. 1985; An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell43:831–840
    [Google Scholar]
  33. Wang D., Liebowitz D., Wang F., Gregory C., Rickinson A., Larson R., Springer T., Kieff E.. 1988; Epstein–Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. J Virol62:4173–4184
    [Google Scholar]
  34. Xu Y., Wong S. H., Zhang T., Subramaniam V. N., Hong W.. 1997; GS15, a 15-kilodalton Golgi soluble N -ethylmaleimide-sensitive factor attachment protein receptor (SNARE) homologous to rbet1. J Biol Chem272:20162–20166
    [Google Scholar]
  35. Zitvogel L., Regnault A., Lozier A., Wolfers J., Flament C., Tenza D., Ricciardi-Castagnoli P., Raposo G., Amigorena S.. 1998; Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med4:594–600
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.18944-0
Loading
/content/journal/jgv/10.1099/vir.0.18944-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error